Tonix Pharmaceuticals (TNXP) Misses Q1 EPS by 17c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• HP shares slide as tech giant forecasts 2027 PC market slump
• AMC Entertainment launches tender offer for $360M in senior notes
• DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)